$384.31
-9.42-2.39%
Pre-Market: 4:34 AM EDT
Comments
Loading...
IDEXX Laboratories Stock Guidance | NASDAQ:IDXX | Benzinga
IDEXX Laboratories issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/03/2025 | IDXX | IDEXX Laboratories | FY | 2025 | $11.74 | $12.24 | $11.84 | $4.05B | $4.17B | $4.15B | Get Alert |
| 11/21/2024 | IDXX | IDEXX Laboratories | FY | 2024 | $10.37 | $10.53 | $10.52 | $3.87B | $3.89B | $3.88B | Get Alert |
| 10/31/2024 | IDXX | IDEXX Laboratories | FY | 2024 | $10.37 | $10.53 | $10.52 | $3.87B | $3.89B | $3.92B | Get Alert |
| 08/06/2024 | IDXX | IDEXX Laboratories | FY | 2024 | $10.31 | $10.59 | $11.05 | $3.88B | $3.94B | $3.94B | Get Alert |
| 05/01/2024 | IDXX | IDEXX Laboratories | FY | 2024 | $10.82 | $11.20 | $11.12 | $3.90B | $3.96B | $3.99B | Get Alert |
| 02/05/2024 | IDXX | IDEXX Laboratories | FY | 2024 | $10.84 | $11.33 | $11.00 | $3.93B | $4.04B | $3.97B | Get Alert |
| 11/01/2023 | IDXX | IDEXX Laboratories | FY | 2023 | $9.74 | $9.90 | $9.83 | $3.63B | $3.65B | $3.68B | Get Alert |
| 08/01/2023 | IDXX | IDEXX Laboratories | FY | 2023 | $9.64 | $9.90 | $9.69 | $3.66B | $3.71B | $3.67B | Get Alert |
| 05/02/2023 | IDXX | IDEXX Laboratories | FY | 2023 | $9.33 | $9.75 | $9.59 | $3.62B | $3.70B | $3.65B | Get Alert |
| 02/06/2023 | IDXX | IDEXX Laboratories | FY | 2023 | $9.27 | $9.75 | $9.50 | $3.59B | $3.69B | $3.62B | Get Alert |
| 11/01/2022 | IDXX | IDEXX Laboratories | FY | 2022 | $7.74 | $7.98 | $7.95 | $3.33B | $3.37B | $3.37B | Get Alert |
| 08/02/2022 | IDXX | IDEXX Laboratories | FY | 2022 | $7.77 | $8.05 | $8.27 | $3.31B | $3.38B | $3.42B | Get Alert |
| 05/04/2022 | IDXX | IDEXX Laboratories | FY | 2022 | $8.11 | $8.35 | $9.44 | $3.39B | $3.46B | $3.54B | Get Alert |
| 02/02/2022 | IDXX | IDEXX Laboratories | FY | 2022 | $9.27 | $9.59 | $9.39 | $3.50B | $3.56B | $3.54B | Get Alert |
| 11/02/2021 | IDXX | IDEXX Laboratories | FY | 2021 | $8.30 | $8.38 | $8.38 | $3.19B | $3.20B | $3.20B | Get Alert |
| 07/30/2021 | IDXX | IDEXX Laboratories | FY | 2021 | $8.20 | $8.36 | $8.10 | $3.17B | $3.21B | $3.14B | Get Alert |
| 05/04/2021 | IDXX | IDEXX Laboratories | FY | 2021 | $7.88 | $8.18 | $7.57 | $3.10B | $3.16B | $3.09B | Get Alert |
| 02/02/2021 | IDXX | IDEXX Laboratories | FY | 2021 | $7.39 | $7.71 | $6.81 | $3.06B | $3.12B | $2.96B | Get Alert |
FAQ
What is the most recent guidance for IDEXX Laboratories (IDXX)?
The most recent guidance for IDEXX Laboratories (IDXX) was reported on February 3, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $11.74 to $12.24, compared to the estimated EPS of $11.84. Additionally, IDEXX Laboratories forecasted revenue between $4.06B and $4.17B for the quarter.
Browse guidance and forecast on all stocks.